A group of attorneys from Young Conaway Stargatt & Taylor LLP and Cooley LLP is representing artificial intelligence-powered drug company BioXcel Therapeutics Inc. in its Chapter 11 case.
Louisiana’s push to halt abortion pills by mail heads back to the Fifth Circuit after a quick trip to the U.S. Supreme Court. An entirely new panel of judges is set to take up the case.
A new program rolled out by the Trump administration that aims to decrease prescription drug prices in the U.S. has been causing consternation among drug companies, which fear the resulting pricing uncertainty could gut licensing deals that were inked long before the program was even on the horizon.